Livshitz Leonid M, Rudy Yoram
Cardiac Bioelectricity and Arrhythmia Center, Washington University in St. Louis, Missouri 63130-4899, USA.
Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2854-66. doi: 10.1152/ajpheart.01347.2006. Epub 2007 Feb 2.
Alternans of cardiac repolarization is associated with arrhythmias and sudden death. At the cellular level, alternans involves beat-to-beat oscillation of the action potential (AP) and possibly Ca(2+) transient (CaT). Because of experimental difficulty in independently controlling the Ca(2+) and electrical subsystems, mathematical modeling provides additional insights into mechanisms and causality. Pacing protocols were conducted in a canine ventricular myocyte model with the following results: 1) CaT alternans results from refractoriness of the sarcoplasmic reticulum Ca(2+) release system; alternation of the L-type calcium current has a negligible effect; 2) CaT-AP coupling during late AP occurs through the sodium-calcium exchanger and underlies AP duration (APD) alternans; 3) increased Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) activity extends the range of CaT and APD alternans to slower frequencies and increases alternans magnitude; its decrease suppresses CaT and APD alternans, exerting an antiarrhythmic effect; and 4) increase of the rapid delayed rectifier current (I(Kr)) also suppresses APD alternans but without suppressing CaT alternans. Thus CaMKII inhibition eliminates APD alternans by eliminating its cause (CaT alternans) while I(Kr) enhancement does so by weakening CaT-APD coupling. The simulations identify combined CaMKII inhibition and I(Kr) enhancement as a possible antiarrhythmic intervention.
心脏复极交替与心律失常和猝死相关。在细胞水平上,交替现象涉及动作电位(AP)以及可能的Ca(2+)瞬变(CaT)逐搏振荡。由于在独立控制Ca(2+)和电系统方面存在实验困难,数学建模为机制和因果关系提供了更多见解。在犬心室肌细胞模型中进行了起搏方案,结果如下:1)CaT交替是由肌浆网Ca(2+)释放系统的不应性引起的;L型钙电流的交替影响可忽略不计;2)AP后期的CaT-AP偶联通过钠钙交换器发生,是AP持续时间(APD)交替的基础;3)Ca(2+)/钙调蛋白依赖性蛋白激酶II(CaMKII)活性增加将CaT和APD交替的范围扩展到更低频率,并增加交替幅度;其降低会抑制CaT和APD交替,发挥抗心律失常作用;4)快速延迟整流电流(I(Kr))增加也会抑制APD交替,但不会抑制CaT交替。因此,抑制CaMKII通过消除其原因(CaT交替)来消除APD交替,而增强I(Kr)则通过减弱CaT-APD偶联来实现。模拟结果表明,联合抑制CaMKII和增强I(Kr)可能是一种抗心律失常干预措施。